The Lachman Blog

Subscribe to our blog


Senator Alexander and Representative Goodlatte Grill OMB on Proposed Generic Drug Labeling Rule

In the latest salvo fired over the controversial FDA proposed rule that would permit generic drug ANDA holders to unilaterally change their drug product warnings, Senator Lamar Alexander, Ranking Member, Committee on Health, Education, Labor & Pensions and Congressman, and Bob Goodlatte, Chairman of the Judiciary Committee asked the Office of Management and Budget’s Administrator of the Office of Information and Regulatory Affairs (OIRA) to explain a few things about the FDA position.

Read More
1 173 174 175 200